Global Cancer Diagnostics Service Production, Demand and Key Producers, 2022-2028
This report studies the global Cancer Diagnostics Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cancer Diagnostics Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Diagnostics Service that contribute to its increasing demand across many markets.
The global Cancer Diagnostics Service market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Cancer Diagnostics Service total market, 2017-2028, (USD Million)
Global Cancer Diagnostics Service total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Cancer Diagnostics Service total market, key domestic companies and share, (USD Million)
Global Cancer Diagnostics Service revenue by player and market share 2017-2022, (USD Million)
Global Cancer Diagnostics Service total market by Type, CAGR, 2017-2028, (USD Million)
Global Cancer Diagnostics Service total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Cancer Diagnostics Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, Abbott, QIAGEN, Siemens Healthcare GmbH and Thermo Fisher Scientific, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Diagnostics Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Cancer Diagnostics Service Market, By Region:
1. How big is the global Cancer Diagnostics Service market?
2. What is the demand of the global Cancer Diagnostics Service market?
3. What is the year over year growth of the global Cancer Diagnostics Service market?
4. What is the total value of the global Cancer Diagnostics Service market?
5. Who are the major players in the global Cancer Diagnostics Service market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Cancer Diagnostics Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Diagnostics Service that contribute to its increasing demand across many markets.
The global Cancer Diagnostics Service market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Cancer Diagnostics Service total market, 2017-2028, (USD Million)
Global Cancer Diagnostics Service total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Cancer Diagnostics Service total market, key domestic companies and share, (USD Million)
Global Cancer Diagnostics Service revenue by player and market share 2017-2022, (USD Million)
Global Cancer Diagnostics Service total market by Type, CAGR, 2017-2028, (USD Million)
Global Cancer Diagnostics Service total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Cancer Diagnostics Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, Abbott, QIAGEN, Siemens Healthcare GmbH and Thermo Fisher Scientific, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Diagnostics Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Cancer Diagnostics Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Breast Cancer
- Blood Cancer
- Lung Cancer
- Colorectal Cancer
- Ovarian Cancer
- Others
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Others
- Illumina
- BGI Genomics Co.,Ltd.
- Agilent Technologies
- Macrogen
- Pacific Biosciences
- Abbott
- QIAGEN
- Siemens Healthcare GmbH
- Thermo Fisher Scientific, Inc.
- Applied DNA Sciences
1. How big is the global Cancer Diagnostics Service market?
2. What is the demand of the global Cancer Diagnostics Service market?
3. What is the year over year growth of the global Cancer Diagnostics Service market?
4. What is the total value of the global Cancer Diagnostics Service market?
5. Who are the major players in the global Cancer Diagnostics Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cancer Diagnostics Service Introduction
1.2 World Cancer Diagnostics Service Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Cancer Diagnostics Service Total Market by Region
1.3.1 World Cancer Diagnostics Service Market Size by Region (2017-2028)
1.3.2 United States Cancer Diagnostics Service Market Size (2017-2028)
1.3.3 China Cancer Diagnostics Service Market Size (2017-2028)
1.3.4 Europe Cancer Diagnostics Service Market Size (2017-2028)
1.3.5 Japan Cancer Diagnostics Service Market Size (2017-2028)
1.3.6 South Korea Cancer Diagnostics Service Market Size (2017-2028)
1.3.7 ASEAN Cancer Diagnostics Service Market Size (2017-2028)
1.3.8 India Cancer Diagnostics Service Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cancer Diagnostics Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cancer Diagnostics Service Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CANCER DIAGNOSTICS SERVICE COMPANIES COMPETITIVE ANALYSIS
2.1 World Cancer Diagnostics Service Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Cancer Diagnostics Service Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Cancer Diagnostics Service in 2021
2.2.3 Global Concentration Ratios (CR8) for Cancer Diagnostics Service in 2021
2.3 Cancer Diagnostics Service Company Evaluation Quadrant
2.4 Cancer Diagnostics Service Market: Overall Company Footprint Analysis
2.4.1 Cancer Diagnostics Service Market: Region Footprint
2.4.2 Cancer Diagnostics Service Market: Company Product Type Footprint
2.4.3 Cancer Diagnostics Service Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Cancer Diagnostics Service Market Comparison
3.1.1 United States VS China: Cancer Diagnostics Service Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Cancer Diagnostics Service Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Cancer Diagnostics Service Major Players and Market Share, 2017-2022
3.2.1 Major Players of Cancer Diagnostics Service in United States, Headquarters (States, Country)
3.2.2 United States Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022)
3.3 China Cancer Diagnostics Service Major Players and Market Share, 2017-2022
3.3.1 Major Players of Cancer Diagnostics Service in China, Headquarters (Province, Country)
3.3.2 China Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Cancer Diagnostics Service Major Players and Market Share, 2017-2022
3.4.1 Major Players of Cancer Diagnostics Service in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Cancer Diagnostics Service Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Breast Cancer
4.2.2 Blood Cancer
4.2.3 Lung Cancer
4.2.4 Colorectal Cancer
4.2.5 Ovarian Cancer
4.2.6 Others
4.3 Market Segment by Type
4.3.1 World Cancer Diagnostics Service Market Size by Type (2017-2022)
4.3.2 World Cancer Diagnostics Service Market Size by Type (2023-2028)
4.3.3 World Cancer Diagnostics Service Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Cancer Diagnostics Service Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospitals
5.2.2 Ambulatory Surgical Centers
5.2.3 Diagnostic Laboratories
5.2.4 Others
5.2.5 Others
5.3 Market Segment by Application
5.3.1 World Cancer Diagnostics Service Market Size by Application (2017-2022)
5.3.2 World Cancer Diagnostics Service Market Size by Application (2023-2028)
5.3.3 World Cancer Diagnostics Service Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Illumina
6.1.1 Illumina Details
6.1.2 Illumina Major Business
6.1.3 Illumina Cancer Diagnostics Service Product and Services
6.1.4 Illumina Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Illumina Recent Developments/Updates
6.1.6 Illumina Competitive Strengths & Weaknesses
6.2 BGI Genomics Co.,Ltd.
6.2.1 BGI Genomics Co.,Ltd. Details
6.2.2 BGI Genomics Co.,Ltd. Major Business
6.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product and Services
6.2.4 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 BGI Genomics Co.,Ltd. Recent Developments/Updates
6.2.6 BGI Genomics Co.,Ltd. Competitive Strengths & Weaknesses
6.3 Agilent Technologies
6.3.1 Agilent Technologies Details
6.3.2 Agilent Technologies Major Business
6.3.3 Agilent Technologies Cancer Diagnostics Service Product and Services
6.3.4 Agilent Technologies Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Agilent Technologies Recent Developments/Updates
6.3.6 Agilent Technologies Competitive Strengths & Weaknesses
6.4 Macrogen
6.4.1 Macrogen Details
6.4.2 Macrogen Major Business
6.4.3 Macrogen Cancer Diagnostics Service Product and Services
6.4.4 Macrogen Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Macrogen Recent Developments/Updates
6.4.6 Macrogen Competitive Strengths & Weaknesses
6.5 Pacific Biosciences
6.5.1 Pacific Biosciences Details
6.5.2 Pacific Biosciences Major Business
6.5.3 Pacific Biosciences Cancer Diagnostics Service Product and Services
6.5.4 Pacific Biosciences Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Pacific Biosciences Recent Developments/Updates
6.5.6 Pacific Biosciences Competitive Strengths & Weaknesses
6.6 Abbott
6.6.1 Abbott Details
6.6.2 Abbott Major Business
6.6.3 Abbott Cancer Diagnostics Service Product and Services
6.6.4 Abbott Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Abbott Recent Developments/Updates
6.6.6 Abbott Competitive Strengths & Weaknesses
6.7 QIAGEN
6.7.1 QIAGEN Details
6.7.2 QIAGEN Major Business
6.7.3 QIAGEN Cancer Diagnostics Service Product and Services
6.7.4 QIAGEN Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 QIAGEN Recent Developments/Updates
6.7.6 QIAGEN Competitive Strengths & Weaknesses
6.8 Siemens Healthcare GmbH
6.8.1 Siemens Healthcare GmbH Details
6.8.2 Siemens Healthcare GmbH Major Business
6.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Product and Services
6.8.4 Siemens Healthcare GmbH Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Siemens Healthcare GmbH Recent Developments/Updates
6.8.6 Siemens Healthcare GmbH Competitive Strengths & Weaknesses
6.9 Thermo Fisher Scientific, Inc.
6.9.1 Thermo Fisher Scientific, Inc. Details
6.9.2 Thermo Fisher Scientific, Inc. Major Business
6.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product and Services
6.9.4 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
6.9.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
6.10 Applied DNA Sciences
6.10.1 Applied DNA Sciences Details
6.10.2 Applied DNA Sciences Major Business
6.10.3 Applied DNA Sciences Cancer Diagnostics Service Product and Services
6.10.4 Applied DNA Sciences Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Applied DNA Sciences Recent Developments/Updates
6.10.6 Applied DNA Sciences Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Cancer Diagnostics Service and Key Manufacturers
7.2 Cancer Diagnostics Service Manufacturing Costs
7.3 Cancer Diagnostics Service Production Process
7.4 Cancer Diagnostics Service Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Cancer Diagnostics Service Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Cancer Diagnostics Service Typical Distributors
8.3 Cancer Diagnostics Service Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cancer Diagnostics Service Introduction
1.2 World Cancer Diagnostics Service Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Cancer Diagnostics Service Total Market by Region
1.3.1 World Cancer Diagnostics Service Market Size by Region (2017-2028)
1.3.2 United States Cancer Diagnostics Service Market Size (2017-2028)
1.3.3 China Cancer Diagnostics Service Market Size (2017-2028)
1.3.4 Europe Cancer Diagnostics Service Market Size (2017-2028)
1.3.5 Japan Cancer Diagnostics Service Market Size (2017-2028)
1.3.6 South Korea Cancer Diagnostics Service Market Size (2017-2028)
1.3.7 ASEAN Cancer Diagnostics Service Market Size (2017-2028)
1.3.8 India Cancer Diagnostics Service Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cancer Diagnostics Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cancer Diagnostics Service Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CANCER DIAGNOSTICS SERVICE COMPANIES COMPETITIVE ANALYSIS
2.1 World Cancer Diagnostics Service Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Cancer Diagnostics Service Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Cancer Diagnostics Service in 2021
2.2.3 Global Concentration Ratios (CR8) for Cancer Diagnostics Service in 2021
2.3 Cancer Diagnostics Service Company Evaluation Quadrant
2.4 Cancer Diagnostics Service Market: Overall Company Footprint Analysis
2.4.1 Cancer Diagnostics Service Market: Region Footprint
2.4.2 Cancer Diagnostics Service Market: Company Product Type Footprint
2.4.3 Cancer Diagnostics Service Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Cancer Diagnostics Service Market Comparison
3.1.1 United States VS China: Cancer Diagnostics Service Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Cancer Diagnostics Service Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Cancer Diagnostics Service Major Players and Market Share, 2017-2022
3.2.1 Major Players of Cancer Diagnostics Service in United States, Headquarters (States, Country)
3.2.2 United States Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022)
3.3 China Cancer Diagnostics Service Major Players and Market Share, 2017-2022
3.3.1 Major Players of Cancer Diagnostics Service in China, Headquarters (Province, Country)
3.3.2 China Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Cancer Diagnostics Service Major Players and Market Share, 2017-2022
3.4.1 Major Players of Cancer Diagnostics Service in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Cancer Diagnostics Service Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Breast Cancer
4.2.2 Blood Cancer
4.2.3 Lung Cancer
4.2.4 Colorectal Cancer
4.2.5 Ovarian Cancer
4.2.6 Others
4.3 Market Segment by Type
4.3.1 World Cancer Diagnostics Service Market Size by Type (2017-2022)
4.3.2 World Cancer Diagnostics Service Market Size by Type (2023-2028)
4.3.3 World Cancer Diagnostics Service Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Cancer Diagnostics Service Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospitals
5.2.2 Ambulatory Surgical Centers
5.2.3 Diagnostic Laboratories
5.2.4 Others
5.2.5 Others
5.3 Market Segment by Application
5.3.1 World Cancer Diagnostics Service Market Size by Application (2017-2022)
5.3.2 World Cancer Diagnostics Service Market Size by Application (2023-2028)
5.3.3 World Cancer Diagnostics Service Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Illumina
6.1.1 Illumina Details
6.1.2 Illumina Major Business
6.1.3 Illumina Cancer Diagnostics Service Product and Services
6.1.4 Illumina Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Illumina Recent Developments/Updates
6.1.6 Illumina Competitive Strengths & Weaknesses
6.2 BGI Genomics Co.,Ltd.
6.2.1 BGI Genomics Co.,Ltd. Details
6.2.2 BGI Genomics Co.,Ltd. Major Business
6.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product and Services
6.2.4 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 BGI Genomics Co.,Ltd. Recent Developments/Updates
6.2.6 BGI Genomics Co.,Ltd. Competitive Strengths & Weaknesses
6.3 Agilent Technologies
6.3.1 Agilent Technologies Details
6.3.2 Agilent Technologies Major Business
6.3.3 Agilent Technologies Cancer Diagnostics Service Product and Services
6.3.4 Agilent Technologies Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Agilent Technologies Recent Developments/Updates
6.3.6 Agilent Technologies Competitive Strengths & Weaknesses
6.4 Macrogen
6.4.1 Macrogen Details
6.4.2 Macrogen Major Business
6.4.3 Macrogen Cancer Diagnostics Service Product and Services
6.4.4 Macrogen Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Macrogen Recent Developments/Updates
6.4.6 Macrogen Competitive Strengths & Weaknesses
6.5 Pacific Biosciences
6.5.1 Pacific Biosciences Details
6.5.2 Pacific Biosciences Major Business
6.5.3 Pacific Biosciences Cancer Diagnostics Service Product and Services
6.5.4 Pacific Biosciences Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Pacific Biosciences Recent Developments/Updates
6.5.6 Pacific Biosciences Competitive Strengths & Weaknesses
6.6 Abbott
6.6.1 Abbott Details
6.6.2 Abbott Major Business
6.6.3 Abbott Cancer Diagnostics Service Product and Services
6.6.4 Abbott Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Abbott Recent Developments/Updates
6.6.6 Abbott Competitive Strengths & Weaknesses
6.7 QIAGEN
6.7.1 QIAGEN Details
6.7.2 QIAGEN Major Business
6.7.3 QIAGEN Cancer Diagnostics Service Product and Services
6.7.4 QIAGEN Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 QIAGEN Recent Developments/Updates
6.7.6 QIAGEN Competitive Strengths & Weaknesses
6.8 Siemens Healthcare GmbH
6.8.1 Siemens Healthcare GmbH Details
6.8.2 Siemens Healthcare GmbH Major Business
6.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Product and Services
6.8.4 Siemens Healthcare GmbH Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Siemens Healthcare GmbH Recent Developments/Updates
6.8.6 Siemens Healthcare GmbH Competitive Strengths & Weaknesses
6.9 Thermo Fisher Scientific, Inc.
6.9.1 Thermo Fisher Scientific, Inc. Details
6.9.2 Thermo Fisher Scientific, Inc. Major Business
6.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product and Services
6.9.4 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
6.9.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
6.10 Applied DNA Sciences
6.10.1 Applied DNA Sciences Details
6.10.2 Applied DNA Sciences Major Business
6.10.3 Applied DNA Sciences Cancer Diagnostics Service Product and Services
6.10.4 Applied DNA Sciences Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Applied DNA Sciences Recent Developments/Updates
6.10.6 Applied DNA Sciences Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Cancer Diagnostics Service and Key Manufacturers
7.2 Cancer Diagnostics Service Manufacturing Costs
7.3 Cancer Diagnostics Service Production Process
7.4 Cancer Diagnostics Service Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Cancer Diagnostics Service Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Cancer Diagnostics Service Typical Distributors
8.3 Cancer Diagnostics Service Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cancer Diagnostics Service Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Cancer Diagnostics Service Market Size by Region (2017-2022) & (USD Million)
Table 3. World Cancer Diagnostics Service Market Size by Region (2023-2028) & (USD Million)
Table 4. World Cancer Diagnostics Service Market Size Market Share by Region (2017-2022)
Table 5. World Cancer Diagnostics Service Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Cancer Diagnostics Service Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Cancer Diagnostics Service Players in 2021
Table 9. World Cancer Diagnostics Service Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Cancer Diagnostics Service Company Evaluation Quadrant
Table 11. Head Office of Key Cancer Diagnostics Service Player
Table 12. Cancer Diagnostics Service Market: Company Product Type Footprint
Table 13. Cancer Diagnostics Service Market: Company Product Application Footprint
Table 14. Cancer Diagnostics Service Mergers & Acquisitions Activity
Table 15. United States VS China Cancer Diagnostics Service Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Cancer Diagnostics Service in United States, Headquarters (States, Country)
Table 17. United States Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Cancer Diagnostics Service Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Cancer Diagnostics Service in China, Company Headquarters (Province, Country)
Table 20. China Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Cancer Diagnostics Service Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Cancer Diagnostics Service in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Cancer Diagnostics Service Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Cancer Diagnostics Service Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Cancer Diagnostics Service Revenue by Type (2017-2022) & (USD Million)
Table 27. World Cancer Diagnostics Service Revenue by Type (2023-2028) & (USD Million)
Table 28. World Cancer Diagnostics Service Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Cancer Diagnostics Service Revenue by Application (2017-2022) & (USD Million)
Table 30. World Cancer Diagnostics Service Revenue by Application (2023-2028) & (USD Million)
Table 31. Illumina Basic Information, Area Served and Competitors
Table 32. Illumina Major Business
Table 33. Illumina Cancer Diagnostics Service Product and Services
Table 34. Illumina Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Illumina Recent Developments/Updates
Table 36. Illumina Competitive Strengths & Weaknesses
Table 37. BGI Genomics Co.,Ltd. Basic Information, Area Served and Competitors
Table 38. BGI Genomics Co.,Ltd. Major Business
Table 39. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product and Services
Table 40. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. BGI Genomics Co.,Ltd. Recent Developments/Updates
Table 42. BGI Genomics Co.,Ltd. Competitive Strengths & Weaknesses
Table 43. Agilent Technologies Basic Information, Area Served and Competitors
Table 44. Agilent Technologies Major Business
Table 45. Agilent Technologies Cancer Diagnostics Service Product and Services
Table 46. Agilent Technologies Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Agilent Technologies Recent Developments/Updates
Table 48. Agilent Technologies Competitive Strengths & Weaknesses
Table 49. Macrogen Basic Information, Area Served and Competitors
Table 50. Macrogen Major Business
Table 51. Macrogen Cancer Diagnostics Service Product and Services
Table 52. Macrogen Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Macrogen Recent Developments/Updates
Table 54. Macrogen Competitive Strengths & Weaknesses
Table 55. Pacific Biosciences Basic Information, Area Served and Competitors
Table 56. Pacific Biosciences Major Business
Table 57. Pacific Biosciences Cancer Diagnostics Service Product and Services
Table 58. Pacific Biosciences Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Pacific Biosciences Recent Developments/Updates
Table 60. Pacific Biosciences Competitive Strengths & Weaknesses
Table 61. Abbott Basic Information, Area Served and Competitors
Table 62. Abbott Major Business
Table 63. Abbott Cancer Diagnostics Service Product and Services
Table 64. Abbott Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Abbott Recent Developments/Updates
Table 66. Abbott Competitive Strengths & Weaknesses
Table 67. QIAGEN Basic Information, Area Served and Competitors
Table 68. QIAGEN Major Business
Table 69. QIAGEN Cancer Diagnostics Service Product and Services
Table 70. QIAGEN Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. QIAGEN Recent Developments/Updates
Table 72. QIAGEN Competitive Strengths & Weaknesses
Table 73. Siemens Healthcare GmbH Basic Information, Area Served and Competitors
Table 74. Siemens Healthcare GmbH Major Business
Table 75. Siemens Healthcare GmbH Cancer Diagnostics Service Product and Services
Table 76. Siemens Healthcare GmbH Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Siemens Healthcare GmbH Recent Developments/Updates
Table 78. Siemens Healthcare GmbH Competitive Strengths & Weaknesses
Table 79. Thermo Fisher Scientific, Inc. Basic Information, Area Served and Competitors
Table 80. Thermo Fisher Scientific, Inc. Major Business
Table 81. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product and Services
Table 82. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 84. Applied DNA Sciences Basic Information, Area Served and Competitors
Table 85. Applied DNA Sciences Major Business
Table 86. Applied DNA Sciences Cancer Diagnostics Service Product and Services
Table 87. Applied DNA Sciences Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 88. Cancer Diagnostics Service Raw Material
Table 89. Key Manufacturers of Cancer Diagnostics Service Raw Materials
Table 90. Cancer Diagnostics Service Typical Distributors
Table 91. Cancer Diagnostics Service Typical Customers
Table 1. World Cancer Diagnostics Service Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Cancer Diagnostics Service Market Size by Region (2017-2022) & (USD Million)
Table 3. World Cancer Diagnostics Service Market Size by Region (2023-2028) & (USD Million)
Table 4. World Cancer Diagnostics Service Market Size Market Share by Region (2017-2022)
Table 5. World Cancer Diagnostics Service Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Cancer Diagnostics Service Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Cancer Diagnostics Service Players in 2021
Table 9. World Cancer Diagnostics Service Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Cancer Diagnostics Service Company Evaluation Quadrant
Table 11. Head Office of Key Cancer Diagnostics Service Player
Table 12. Cancer Diagnostics Service Market: Company Product Type Footprint
Table 13. Cancer Diagnostics Service Market: Company Product Application Footprint
Table 14. Cancer Diagnostics Service Mergers & Acquisitions Activity
Table 15. United States VS China Cancer Diagnostics Service Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Cancer Diagnostics Service in United States, Headquarters (States, Country)
Table 17. United States Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Cancer Diagnostics Service Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Cancer Diagnostics Service in China, Company Headquarters (Province, Country)
Table 20. China Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Cancer Diagnostics Service Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Cancer Diagnostics Service in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Cancer Diagnostics Service Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Cancer Diagnostics Service Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Cancer Diagnostics Service Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Cancer Diagnostics Service Revenue by Type (2017-2022) & (USD Million)
Table 27. World Cancer Diagnostics Service Revenue by Type (2023-2028) & (USD Million)
Table 28. World Cancer Diagnostics Service Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Cancer Diagnostics Service Revenue by Application (2017-2022) & (USD Million)
Table 30. World Cancer Diagnostics Service Revenue by Application (2023-2028) & (USD Million)
Table 31. Illumina Basic Information, Area Served and Competitors
Table 32. Illumina Major Business
Table 33. Illumina Cancer Diagnostics Service Product and Services
Table 34. Illumina Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Illumina Recent Developments/Updates
Table 36. Illumina Competitive Strengths & Weaknesses
Table 37. BGI Genomics Co.,Ltd. Basic Information, Area Served and Competitors
Table 38. BGI Genomics Co.,Ltd. Major Business
Table 39. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product and Services
Table 40. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. BGI Genomics Co.,Ltd. Recent Developments/Updates
Table 42. BGI Genomics Co.,Ltd. Competitive Strengths & Weaknesses
Table 43. Agilent Technologies Basic Information, Area Served and Competitors
Table 44. Agilent Technologies Major Business
Table 45. Agilent Technologies Cancer Diagnostics Service Product and Services
Table 46. Agilent Technologies Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Agilent Technologies Recent Developments/Updates
Table 48. Agilent Technologies Competitive Strengths & Weaknesses
Table 49. Macrogen Basic Information, Area Served and Competitors
Table 50. Macrogen Major Business
Table 51. Macrogen Cancer Diagnostics Service Product and Services
Table 52. Macrogen Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Macrogen Recent Developments/Updates
Table 54. Macrogen Competitive Strengths & Weaknesses
Table 55. Pacific Biosciences Basic Information, Area Served and Competitors
Table 56. Pacific Biosciences Major Business
Table 57. Pacific Biosciences Cancer Diagnostics Service Product and Services
Table 58. Pacific Biosciences Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Pacific Biosciences Recent Developments/Updates
Table 60. Pacific Biosciences Competitive Strengths & Weaknesses
Table 61. Abbott Basic Information, Area Served and Competitors
Table 62. Abbott Major Business
Table 63. Abbott Cancer Diagnostics Service Product and Services
Table 64. Abbott Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Abbott Recent Developments/Updates
Table 66. Abbott Competitive Strengths & Weaknesses
Table 67. QIAGEN Basic Information, Area Served and Competitors
Table 68. QIAGEN Major Business
Table 69. QIAGEN Cancer Diagnostics Service Product and Services
Table 70. QIAGEN Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. QIAGEN Recent Developments/Updates
Table 72. QIAGEN Competitive Strengths & Weaknesses
Table 73. Siemens Healthcare GmbH Basic Information, Area Served and Competitors
Table 74. Siemens Healthcare GmbH Major Business
Table 75. Siemens Healthcare GmbH Cancer Diagnostics Service Product and Services
Table 76. Siemens Healthcare GmbH Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Siemens Healthcare GmbH Recent Developments/Updates
Table 78. Siemens Healthcare GmbH Competitive Strengths & Weaknesses
Table 79. Thermo Fisher Scientific, Inc. Basic Information, Area Served and Competitors
Table 80. Thermo Fisher Scientific, Inc. Major Business
Table 81. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product and Services
Table 82. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 84. Applied DNA Sciences Basic Information, Area Served and Competitors
Table 85. Applied DNA Sciences Major Business
Table 86. Applied DNA Sciences Cancer Diagnostics Service Product and Services
Table 87. Applied DNA Sciences Cancer Diagnostics Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 88. Cancer Diagnostics Service Raw Material
Table 89. Key Manufacturers of Cancer Diagnostics Service Raw Materials
Table 90. Cancer Diagnostics Service Typical Distributors
Table 91. Cancer Diagnostics Service Typical Customers
LIST OF FIGURES
Figure 1. Cancer Diagnostics Service Picture
Figure 2. World Cancer Diagnostics Service Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Cancer Diagnostics Service Total Market Size (2017-2028) & (USD Million)
Figure 4. World Cancer Diagnostics Service Market Size Market Share by Region (2017-2028)
Figure 5. United States Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 6. China Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 7. Europe Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 8. Japan Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 11. India Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 12. Cancer Diagnostics Service Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Cancer Diagnostics Service by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Cancer Diagnostics Service Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Cancer Diagnostics Service Markets in 2021
Figure 17. United States VS China: Cancer Diagnostics Service Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Cancer Diagnostics Service Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Cancer Diagnostics Service Market Size Market Share by Type in 2021
Figure 20. Breast Cancer
Figure 21. Blood Cancer
Figure 22. Lung Cancer
Figure 23. Colorectal Cancer
Figure 24. Ovarian Cancer
Figure 25. Others
Figure 26. World Cancer Diagnostics Service Market Size Market Share by Type (2017-2028)
Figure 27. World Cancer Diagnostics Service Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 28. World Cancer Diagnostics Service Market Size Market Share by Application in 2021
Figure 29. Hospitals
Figure 30. Ambulatory Surgical Centers
Figure 31. Diagnostic Laboratories
Figure 32. Others
Figure 33. World Cancer Diagnostics Service Market Size Market Share by Application (2017-2028)
Figure 34. Manufacturing Cost Structure Analysis of Cancer Diagnostics Service in 2021
Figure 35. Manufacturing Process Analysis of Cancer Diagnostics Service
Figure 36. Cancer Diagnostics Service Industrial Chain
Figure 37. Distribution Channel Breakdown for Cancer Diagnostics Service Shipments (%): 2017-2028
Figure 38. Direct Channel Pros & Cons
Figure 39. Indirect Channel Pros & Cons
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Cancer Diagnostics Service Picture
Figure 2. World Cancer Diagnostics Service Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Cancer Diagnostics Service Total Market Size (2017-2028) & (USD Million)
Figure 4. World Cancer Diagnostics Service Market Size Market Share by Region (2017-2028)
Figure 5. United States Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 6. China Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 7. Europe Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 8. Japan Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 11. India Cancer Diagnostics Service Market Size (2017-2028) & (USD Million)
Figure 12. Cancer Diagnostics Service Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Cancer Diagnostics Service by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Cancer Diagnostics Service Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Cancer Diagnostics Service Markets in 2021
Figure 17. United States VS China: Cancer Diagnostics Service Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Cancer Diagnostics Service Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Cancer Diagnostics Service Market Size Market Share by Type in 2021
Figure 20. Breast Cancer
Figure 21. Blood Cancer
Figure 22. Lung Cancer
Figure 23. Colorectal Cancer
Figure 24. Ovarian Cancer
Figure 25. Others
Figure 26. World Cancer Diagnostics Service Market Size Market Share by Type (2017-2028)
Figure 27. World Cancer Diagnostics Service Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 28. World Cancer Diagnostics Service Market Size Market Share by Application in 2021
Figure 29. Hospitals
Figure 30. Ambulatory Surgical Centers
Figure 31. Diagnostic Laboratories
Figure 32. Others
Figure 33. World Cancer Diagnostics Service Market Size Market Share by Application (2017-2028)
Figure 34. Manufacturing Cost Structure Analysis of Cancer Diagnostics Service in 2021
Figure 35. Manufacturing Process Analysis of Cancer Diagnostics Service
Figure 36. Cancer Diagnostics Service Industrial Chain
Figure 37. Distribution Channel Breakdown for Cancer Diagnostics Service Shipments (%): 2017-2028
Figure 38. Direct Channel Pros & Cons
Figure 39. Indirect Channel Pros & Cons
Figure 40. Methodology
Figure 41. Research Process and Data Source
